📰 Synaptic Plasticity News
Synaptic Plasticity News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Synaptic Plasticity. Real-time updates on events, politics, business and more.
February 6, 2024
It is well known that protein tau forms aggregates in the brain in neurodegenerative diseases such as Alzheimer’s disease (AD) that are also known as tauopathies. Accumulation of protein tau in the brain leads to the cell toxicity and promotes the loss of synaptic plasticity, which in turn causes memory loss. As reported on Feb. 1, 2024, in The Journal of Clinical Investigation, assistant professor Tara Tracy and her research team from the Buck Institute for Research on Aging have discovered a...
December 27, 2023
Pentagon services are working on projects to increase warfighters’ abilities including brain stimulation.
November 17, 2023
The Society for Neuroscience named MIT Picower Professor Mark Bear a co-recipient of the 2023 Julius Axelrod Prize for his synaptic plasticity research, its translation to potential amblyopia and autism treatments, and his career of mentorship.
November 3, 2023
Scientists have conducted research on mice after subjecting them to brief, temporary sleep deprivation. Here's what happened.
October 3, 2023
‘My life has been feeling so plotless, by which I mean that I am stable. Maybe it is boring to read but I don’t think it’s not worth expressing.’
June 17, 2023
Flavanols Deficiency and Memory Decline: Unraveling the Connection - Diabetes Health - Memory decline and cognitive impairment are significant concerns of aging populations. As researchers continue to delve into the intricate workings of the
September 16, 2021
Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the...
May 20, 2021
Abstract Diabetic encephalopathy, a severe complication of diabetes mellitus, is characterized by neuroinflammation and aberrant synaptogenesis in the hippocampus leading to cognitive decline. Mammalian target of rapamycin (mTOR) is associated with cognition impairment. Nuclear factor-κB (NF-κB) is a transcription factor of proinflammatory cytokines. Although mTOR has been ever implicated in processes occurring in neuroinflammation, the role of this enzyme on NF-κB signaling pathway remains ...
May 1, 2021
Shahriar SheikhBahaei, Ph.D. Dr. SheikhBahaei’s interest in neuroscience stemmed from the usual combination of an aptitude for science and a medical problem (stuttering) that brought him into bioscience at a young age. Dr. SheikhBahaei received his bachelor’s degree from the University of California at Berkeley, where he worked with Dr. Bob Zucker on the regulation of neurotransmitter release and Dr. John Rubenstein (UC San Francisco) on development of GABAergic neurons in basal ganglia. Dr...
March 8, 2021
The Atlantic We have been doing this so long, we’re forgetting how to be normal. Peter Marlow / Magnum I first became aware that I was losing my mind in late December. It was a Friday night, the start of my 40-somethingth pandemic weekend: Hours and hours with no work to distract me, and outside temperatures prohibitive of anything other than staying in. I couldn’t for the life of me figure out how to fill the time. “What did I used to … do on weekends?” I asked my boyfriend, like a s...